[1]孙华,杨雁,李琳,等.正电子放射性显像剂18F—FDG的研究进展[J].国际放射医学核医学杂志,2010,34(6):333-336,362.[doi:10.3760/cma.j.issn.1673-4114,2010.06.004]
 SUN Hua,YANG Yan,LI Lin,et al.The progress of reserch on positron radioactive 18F-FDG[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(6):333-336,362.[doi:10.3760/cma.j.issn.1673-4114,2010.06.004]
点击复制

正电子放射性显像剂18F—FDG的研究进展(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
34
期数:
2010年第6期
页码:
333-336,362
栏目:
实验核医学
出版日期:
1900-01-01

文章信息/Info

Title:
The progress of reserch on positron radioactive 18F-FDG
作者:
孙华1 杨雁2 李琳1 杨发科1 赵雷1
1. 昆明医学院第三附属医院云南省肿瘤医院PET/CT中心, 650018;
2. 昆明医学院第三附属医院云南省肿瘤医院药剂科, 650018
Author(s):
SUN Hua1 YANG Yan2 LI Lin1 YANG Fa-ke1 ZHAO Lei1
Center of PET/CT, the Third Affiliated Hospital of Kunming Medical College, Tumor Hospital of Yunnan Province, Kuming 650018, China
关键词:
氟脱氧葡萄糖F18质量控制药代动力学工艺学制药
Keywords:
Fluorodeoxyglucose F18Quality controlPharmacokineticsTechnologypharmaceutical
DOI:
10.3760/cma.j.issn.1673-4114,2010.06.004
摘要:
18F-FDG是PET-CT影像诊断重要的示踪剂之一,采用亲核取代反应制备18F-FDG比亲电取代反应更优越,因此,前者取代后者将势在必行。全自动合成模块工艺对放射性药物的规模化生产以及临床上的广泛应用起到了推动作用。近年来,新技术手段在18F-FDG合成模块中的应用也引起了人们的广泛关注。作为以静脉注射方式给药的示踪剂,18F-FDG的质量控制要求严格。先进的检测手段以及药品生产和质量管理规范的实施为18F-FDG的质量控制提供了保证。对18F-FDG的代谢动力学研究发现,该示踪剂静脉注射后的代谢过程符合三室模型,为临床用药提供了依据。该文从合成原理、工艺流程、质量控制、代谢分布与临床应用等几个方面对18F-FDG的研究进展进行综述。
Abstract:
As one of the most important tracer for PET-CT, the preparation of 18F-FDG by nucleophilic substitution is better than electrophilic substitution,therefore the substitution of the former for the latter is imperative. Automatic synthesis module technology has powerful function on the large-scale production of radioactive drugs and widely clinical been used. In recent years the application of new technology in 18F-FDG synthesis module is very fascinating. The requirement for quality control of 18F-FDG is tremendously strict, for which the administration way of 18F-FDG is intravenous injection. The advanced detective methods and the standardization of Good Manufacturing Practice are guarantee to 18F-FDG quality control. The researches on pharmacokinetics of 18F-FDG show that the metabolic process accords with three-compartment model after intravenous, which provides a basis for clinical medication. In this paper, we review the 18F-FDG in detail from the principle of synthesis, craft process, quality control, metabolic distribution and clinical application and so on.

参考文献/References:

[1] Ido T, Wan CN, Fowler JS, et al. Fluorination with F2. A convenient synthesis of 2-deoxy-2-fluoro-D-glucose. J Org Chem, 1977, 42(13):2341-2342.
[2] Coenen HH, Pike VW, Stocklin G, et al. Recommendation for a practical production of[2-18F] fluoro-2-deoxy-D-glucose. Appl Radiat Isot, 1987, 38(8):605-610.
[3] Brodack JW, Dence CS, Kilbourn MR, et al. Robotic production of 2deoxy-2[18F]fluoro-D-glucose:a routine method of synthesis using tetrabutylammonium[18F]fluoride. Appl Radiat Isot, 1988, 39(7):699-703.
[4] Kilbourn MR, Hood JT, Welch MJ. A simple 18O water target for 18F production. Int J Appl Radiat Isot, 1984, 35(7):599-602.
[5] Kilbourn MR, Jerabek PA, Welch MJ. An improved[18O] water target for[18F]fluoride production. Int J Appl Radiat Isot, 1985, 36(4):327-328.
[6] Bogni A, Pascali C, Iwata R, et al.[18F]FDG synthesis by Anatech RB-86 robotic system:Improvements and general considerations. J Radioanal NuclChem, 1998, 230(1-2):45-50.
[7] Toorengian SA, Mulholland GK, Jewett DM, et al. Routine producJ tion of 2-deoxy-2-[18F]fluoro-D-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin. Nucl Med Biol, 1990, 17(3):273-279.
[8] Kim HW, Jeong JM, Lee YS, et al. Rapid synthesis of[18F]FDG without an evaporation step using an ionic liquid. Appl Radiat Isot, 2004, 61(6):1241-1246.
[9] Hamacher K, Hirschfelder T, Coenen HH. Electrochemical cell for separation of[18F]fluoride from irradiated 18O-water and subsequent no carrier added nucleophilic fluorination. Appl Radiat Isot, 2002, 56(3):519-523.
[10] Chaly T, Mattacchieri R, Velez JW, et al. A large scale manual production of[18F]FDG using a synthetic unit made of sterile disposable components an.d operated by a Master Slave Manipulator. Appl Radiat Isot, 1990, 41(1):29-34.
[11] Culbert PA, Adam M J, Hurtado ET, et al. Automated synthesis of[18F]FDG using tetrabutylammonium bicarbonate. Appl Radiat Isot, 1995, 46(9):887-891.
[12] Alexoff DL, Russell JAG, Shiue CY, et al. Modular automation in PET tracer manufacturing:application of an autosynthesizer to the production of 2-deoxy-2-[18F]fluoro-D-glucose. Appl Radiat Isot, 1986, 37(10):1045-1061.
[13] Mock BH, Vavrek MT, Mulholland GK. Back-to-back "One-Pot"[18F]FDG syntheses in a single Siemens-CTI chemistry process control unit. Nucl Med Biol, 1996, 23(4):497-501.
[14] 朱丽,侯丽雅,章维一.基于微流体数字化技术的微化学反应器.中国机械工程,2007,18(5):597-599.
[15] 张锦明,张书文,田嘉禾,等.影响2-18F-2-脱氢-β-D-葡萄糖合成效率因素初探.同位素,2003,16(1):30-34.
[16] Mulholland GK. Simple rapid hydrolysis of acetyl protecting groups in the FDG synthesis using cation exchange resins. Nuel Med Biol, 1995, 22(1):19-23.
[17] Füchtner F, Steinbach J, Mading P, et al. Basic hydrolysis of 2-[18F] fluoro-l,3,d,6-tetra-O-acetyl-D-glucose in the preparation of 2-[18F]fluoro-2-deoxy-D-glucose. Appl Radiat Isot, 1996, 47(1):61-66.
[18] The United States Pharmacopoeia Convention. The United States Pharmacopeia. 26 th ed. 2003:808-810.
[19] 叶肇云,齐秀珍.18FDG注射液放化纯度的测定.同位素,2004,17(2):104-107.
[20] Ma Y, Huang BX, Channing MA, et al. Quantification of Kryptofix 2.2.2 in 2-[18F]FDG and other radiopharmaceuticals by LC/MS/MS. Nucl Med Biol, 2002, 29(1):125-129.
[21] Mock BH, Winkle W, Vavrek MT, et al. A color spot test for the detection of Kryptofix 2.2.2 in[18F]FDG preparations. Nucl Med Biol, 1997, 24(2):193-195.
[22] 张锦明,田嘉禾.18F-FDG的质量控制及方法.中华核医学杂志,2005,25(6):383-384.
[23] Hunter GJ, Hamberg LM, Alpert NM. Simplified measurement of deoxyglucose utilization rate. J Nucl Med, 1996, 37(6):950-955.
[24] Phelps ME, Hoffman E J, Selin C, et al. Investigation of[18F] 2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism. J Nucl Med, 1978, 19(12):1311-1319.
[25] Gallagher BM, Ansari A, Atkins H, et al. Radiopharmaceuticals XXVⅡ. 18F-labeled 2-deoxy-2-fluoro-d-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo:tissue distribution and imaging studies in animals. J Nucl Med, 1977,18(10):990-996.
[26] 李彪,朱承谟.正电子放射性药物的临床应用与进展.诊断学理论与实践,2005,4(2):93-95.
[27] 陈泽龙,王楷堂,李天然,等.18F-FDG显像剂的制备及其在肿瘤诊断中的作用评价.福建医药杂志,2006,28(1):1-3.

相似文献/References:

[1]张奇洲,李毓斌,李肖红,等.11C-乙酸盐的自动化合成影响因素的考察及质量控制[J].国际放射医学核医学杂志,2016,40(1):6.[doi:10.3760/cma.j.issn.1673-4114.2016.01.002]
 Zhang Qizhou,Li Yubin,Li Xiaohong,et al.Study of the automated synthesis influence factors and quality control of 11C-acetate[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):6.[doi:10.3760/cma.j.issn.1673-4114.2016.01.002]
[2]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
 Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[3]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
 You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[4]贺小红,周新韩,高明勇,等.模型模拟修改部分扫描参数加速MR扫描的方法可行性探讨[J].国际放射医学核医学杂志,2016,40(4):267.[doi:10.3760/cma.j.issn.1673-4114.2016.04.006]
 He Xiaohong,Zhou Xinhan,Gao Mingyong,et al.Feasibility of accelerating MR scan by modifying part of scanning parameters:a phantom simulation study[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):267.[doi:10.3760/cma.j.issn.1673-4114.2016.04.006]
[5]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
 Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[6]李菲,黄俊星,张俊.18F-FDG PET/CT在食管癌中的临床应用[J].国际放射医学核医学杂志,2016,40(4):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
 Li Fei,Huang Junxing,Zhang Jun.The clinical application of 18F-FDG PET/CT in esophageal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
[7]卢顺琦,吴锦海,刘海宽,等.上海市数字化乳腺x射线摄影装置质量控制检测分析[J].国际放射医学核医学杂志,2015,39(5):381.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 006]
 lu shunqi,wu jinhai,liu haikuan,et al.Quality analysis of digital mammography facilities in shanghai[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):381.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 006]
[8]拓飞,张庆,张京,等.2014年度全国放射性核素γ能谱分析质量控制比对[J].国际放射医学核医学杂志,2015,39(5):401.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 011]
 tuo fei,zhang qing,zhang jing,et al.nationwide intercomparison for radionuclide analyses through γ-spectrometry method in 2014[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):401.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 011]
[9]许靖,李肖红,秦永德,等.帕金森病脑部葡萄糖代谢和脑多巴胺转运体PET显像特点的临床研究[J].国际放射医学核医学杂志,2016,40(5):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
 Xu Jing,Li Xiaohong,Qin Yongde,et al.Clinical study of brain glucose metabolism and brain dopamine transporter PET imaging in patients with Parkinson’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
[10]曹登敏,林美福,陈文新,等.继发性骨淋巴瘤的18F-FDG PET/CT影像学表现[J].国际放射医学核医学杂志,2016,40(6):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
 Cao Dengmin,Lin Meifu,Chen Wenxin,et al.Analysis on 18F-FDG PET/CT imaging characteristics in secondary bone lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]

备注/Memo

备注/Memo:
收稿日期:2010-09-21。
通讯作者:赵雷(E-mail:petct163@163.com)
更新日期/Last Update: 1900-01-01